REGEN BIOPHARMA, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $14.7M | $1.2M | $727.2K |
| FY2022 | $8.6M | $559.0K | $51.2K |
| FY2023 | $5.5M | $353.6K | $121.0K |
| FY2024 | $5.4M | $161.1K | $716 |
| FY2025 | $6.6M | $274.6K | $69.6K |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $14.7M | $1.2M | $727.2K |
| FY2022 | $8.6M | $559.0K | $51.2K |
| FY2023 | $5.5M | $353.6K | $121.0K |
| FY2024 | $5.4M | $161.1K | $716 |
| FY2025 | $6.6M | $274.6K | $69.6K |